Northern Trust Corp Ikena Oncology, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 48,109 shares of IKNA stock, worth $75,531. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,109

Previous 216,851 77.81%

Holding current value

$75,531

Previous $357,000 76.75%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1.6 - $1.85 $269,987 - $312,172	-168,742 Reduced 77.81%	48,109 $83,000
Q2 2024 Aug 14, 2024	SELL	$1.24 - $1.82 $21,598 - $31,700	-17,418 Reduced 7.44%	216,851 $357,000
Q1 2024 May 14, 2024	SELL	$1.27 - $2.0 $5,464 - $8,606	-4,303 Reduced 1.8%	234,269 $332,000
Q4 2023 Feb 13, 2024	BUY	$1.33 - $4.4 $53,944 - $178,464	40,560 Added 20.48%	238,572 $469,000
Q3 2023 Nov 13, 2023	BUY	$4.09 - $6.43 $84,532 - $132,895	20,668 Added 11.65%	198,012 $857,000
Q2 2023 Aug 11, 2023	BUY	$3.5 - $7.31 $512,939 - $1.07 Million	146,554 Added 475.98%	177,344 $1.16 Million
Q1 2023 May 15, 2023	BUY	$2.62 - $4.97 $9,618 - $18,244	3,671 Added 13.54%	30,790 $106,000
Q4 2022 Feb 13, 2023	SELL	$2.0 - $3.7 $230 - $425	-115 Reduced 0.42%	27,119 $72,000
Q3 2022 Nov 14, 2022	BUY	$3.46 - $6.0 $40,828 - $70,800	11,800 Added 76.45%	27,234 $97,000
Q2 2022 Aug 12, 2022	SELL	$3.23 - $7.4 $599,959 - $1.37 Million	-185,746 Reduced 92.33%	15,434 $69,000
Q1 2022 May 13, 2022	SELL	$5.61 - $13.85 $38,624 - $95,357	-6,885 Reduced 3.31%	201,180 $1.23 Million
Q4 2021 Feb 08, 2022	BUY	$10.52 - $16.96 $1.22 Million - $1.97 Million	116,308 Added 126.76%	208,065 $2.61 Million
Q3 2021 Nov 15, 2021	BUY	$9.82 - $15.23 $65,744 - $101,964	6,695 Added 7.87%	91,757 $1.16 Million
Q2 2021 Aug 13, 2021	BUY	$13.27 - $26.0 $1.13 Million - $2.21 Million	85,062 New	85,062 $1.19 Million

Others Institutions Holding IKNA

# of Institutions

Shares Held

30.6M

Call Options Held

Put Options Held

View Full List

About Ikena Oncology, Inc.

Ticker IKNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,257,500
Market Cap $56.9M
Description
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...

More about IKNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Ikena Oncology, Inc. Transaction History